samedan logo
 
 
spacer
home > pmps > autumn 2020 > the fight against plastic pollution
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

The Fight Against Plastic Pollution

The complex challenges of plastic pollution have been looming over the pharmaceutical industry for a number of years. Following a series of highprofile documentaries focusing on the growing occurrences of plastic being found in our oceans, this issue has never been more front-of-mind to a mainstream audience. Now, as the world looks towards the use of PPE, the spotlight appears to be back on pharma companies and what changes they can make to stop the spread of plastics contaminating oceans.

Plastic (Not-So) Fantastic

Plastic has an important role to play in the pharma industry. While in some industries it forms part of unnecessary packaging, there is no denying that it has functional properties for pharma companies. Whether part of protective packaging for pills, such as paracetamol, or through respiratory items like inhalers, its role and importance in this sector has grown over the years.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
With over 30 years’ experience working for, and with, leading global manufacturers, retailers, and associated supply chain organisations, Kimberly Carey Coffin is a Global Technical Director for Supply Chain Assurance at Lloyd’s Register.

An experienced and recognised sustainability expert, Dave Garforth is part of a senior leadership team of standards and certification professionals who founded the Responsible Plastic Management Program.

John Hamill is a Respiratory/Diabetic Specialist Independent Prescribing GP Pharmacist and Pharmaceutical Associate of the Responsible Plastic Management Program.
spacer
Kimberly Carey Coffin
spacer
spacer
spacer
Dave Garforth
spacer
spacer
spacer
John Hamill
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Tempus Announces Agreement With Janssen R&D to Leverage AI/ML and Real-World Evidence to Enhance the Discovery and Development of Oncology Therapies

Tempus, a leader in artificial intelligence and precision medicine, today announced the expansion of its multi-year agreement with Janssen Research & Development, LLC (Janssen).
More info >>

White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement